These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 8561868

  • 1. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S, Bottorff D, Stone JC.
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [Abstract] [Full Text] [Related]

  • 2. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
    Marshall MS, Hettich LA.
    Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA, Paris M, Villafranca E, Kirshmeier P, Willumsen BM, Wolfman A.
    Oncogene; 1995 Aug 03; 11(3):447-54. PubMed ID: 7630628
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S, Maekawa M, Nakamura S.
    Oncogene; 1992 Mar 03; 7(3):481-5. PubMed ID: 1549362
    [Abstract] [Full Text] [Related]

  • 7. Control of ras activation.
    Downward J.
    Cancer Surv; 1996 Mar 03; 27():87-100. PubMed ID: 8909796
    [Abstract] [Full Text] [Related]

  • 8. A conserved region of c-Ha-Ras is required for efficient GTPase stimulation by GTPase activating protein but not neurofibromin.
    Yoder-Hill J, Golubic M, Stacey DW.
    J Biol Chem; 1995 Nov 17; 270(46):27615-21. PubMed ID: 7499225
    [Abstract] [Full Text] [Related]

  • 9. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
    Hiatt KK, Ingram DA, Zhang Y, Bollag G, Clapp DW.
    J Biol Chem; 2001 Mar 09; 276(10):7240-5. PubMed ID: 11080503
    [Abstract] [Full Text] [Related]

  • 10. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N, Ricca C, Fletcher J, Glover T, Seizinger BR, Manne V.
    Cancer Res; 1995 Aug 15; 55(16):3569-75. PubMed ID: 7627966
    [Abstract] [Full Text] [Related]

  • 11. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
    Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K.
    Nat Genet; 1996 Feb 15; 12(2):144-8. PubMed ID: 8563751
    [Abstract] [Full Text] [Related]

  • 12. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
    Warne PH, Viciana PR, Downward J.
    Nature; 1993 Jul 22; 364(6435):352-5. PubMed ID: 8332195
    [Abstract] [Full Text] [Related]

  • 13. Direct measurement of the binding of RAS to neurofibromin using a scintillation proximity assay.
    Skinner RH, Picardo M, Gane NM, Cook ND, Morgan L, Rowedder J, Lowe PN.
    Anal Biochem; 1994 Dec 22; 223(2):259-65. PubMed ID: 7887472
    [Abstract] [Full Text] [Related]

  • 14. Coupling of ras p21 signalling and GTP hydrolysis by GTPase activating proteins.
    McCormick F.
    Philos Trans R Soc Lond B Biol Sci; 1992 Apr 29; 336(1276):43-7; discussion 47-8. PubMed ID: 1351295
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of rasGAP and neurofibromatosis gene product activities.
    Bollag G, McCormick F.
    Nature; 1991 Jun 13; 351(6327):576-9. PubMed ID: 1904555
    [Abstract] [Full Text] [Related]

  • 16. Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
    Stone JC, Colleton M, Bottorff D.
    Mol Cell Biol; 1993 Dec 13; 13(12):7311-20. PubMed ID: 8246952
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
    Gutmann DH, Boguski M, Marchuk D, Wigler M, Collins FS, Ballester R.
    Oncogene; 1993 Mar 13; 8(3):761-9. PubMed ID: 8437860
    [Abstract] [Full Text] [Related]

  • 18. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
    Barlat I, Schweighoffer F, Chevallier-Multon MC, Duchesne M, Fath I, Landais D, Jacquet M, Tocque B.
    Oncogene; 1993 Jan 13; 8(1):215-8. PubMed ID: 7999142
    [Abstract] [Full Text] [Related]

  • 19. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.
    Rey I, Taylor-Harris P, van Erp H, Hall A.
    Oncogene; 1994 Mar 13; 9(3):685-92. PubMed ID: 8108110
    [Abstract] [Full Text] [Related]

  • 20. Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.
    Patel G, MacDonald MJ, Khosravi-Far R, Hisaka MM, Der CJ.
    Oncogene; 1992 Feb 13; 7(2):283-8. PubMed ID: 1549350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.